ECO Animal Health has released its unaudited trading update for the year ending 31 March 2026, reflecting strong trading in the first half having continued into the second half of the year to deliver year-on-year revenue growth of c8% (our estimate: +3.8%) slightly ahead of market expectations (consensus: £83.5m, our estimate: £82.6m; FY25: £79.6m). North America and Latin America are highlights, despite currency and tariff headwinds. Given improved gross margins, ECO expects a material increase ....
